NUTF2
gene geneOn this page
Also known as NTF2PP15
Summary
NUTF2 (nuclear transport factor 2, HGNC:13722) is a protein-coding gene on chromosome 16q22.1, encoding Nuclear transport factor 2 (P61970). Mediates the import of GDP-bound RAN from the cytoplasm into the nucleus which is essential for the function of RAN in cargo receptor-mediated nucleocytoplasmic transport. It is a common-essential gene (DepMap: required in 99.3% of cancer cell lines).
This gene encodes a cytosolic factor that facilitates protein transport into the nucleus. The encoded protein is required for nuclear import of the small Ras-like GTPase, Ran which is involved in numerous cellular processes. This protein also interacts with the nuclear pore complex glycoprotein p62.
Source: NCBI Gene 10204 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 11 total
- Expression (HPA): Low tissue specificity — highest in tongue, skeletal muscle, supraoptic nucleus
- GTEx eGene: eQTL in 9 tissues, sQTL in 2 (q < 0.05)
- Cancer dependency (DepMap): dependent in 99.3% of screened cell lines (common-essential)
- Constraint (gnomAD): pLI 0.99 (loss-of-function intolerant), LOEUF 0.40 (moderately constrained)
- MANE Select transcript:
NM_005796
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13722 |
| Approved symbol | NUTF2 |
| Name | nuclear transport factor 2 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NTF2, PP15 |
| Ensembl gene | ENSG00000102898 |
| Ensembl biotype | protein_coding |
| OMIM | 605813 |
| Entrez | 10204 |
Gene structure
Transcript identifiers
Ensembl transcripts: 38 — 37 protein_coding, 1 retained_intron
MANE Select: ENST00000219169
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 3, TSL 3: 3
ENST00000219169, ENST00000567105, ENST00000568233, ENST00000568390, ENST00000568396, ENST00000569436, ENST00000570026, ENST00000587481, ENST00000700610, ENST00000700611, ENST00000700612, ENST00000700613, ENST00000700614, ENST00000700615, ENST00000899783, ENST00000899784, ENST00000899785, ENST00000899786, ENST00000899787, ENST00000939627, ENST00000939628, ENST00000939629, ENST00000939630, ENST00000939631, ENST00000939632, ENST00000969121, ENST00001024898, ENST00001091867, ENST00001091868, ENST00001091869, ENST00001091870, ENST00001091871, ENST00001091872, ENST00001091873, ENST00001091874, ENST00001091875, ENST00001091876, ENST00001137350
RefSeq mRNA: 5 — MANE Select: NM_005796
NM_001322038, NM_001322039, NM_001322040, NM_001322041, NM_005796
CCDS: CCDS10848
Canonical transcript exons
ENST00000219169 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001047772 | 67846933 | 67846985 |
| ENSE00003601795 | 67868340 | 67868411 |
| ENSE00003651473 | 67865102 | 67865229 |
| ENSE00003980331 | 67870800 | 67872567 |
| ENSE00003980332 | 67868501 | 67868599 |
Expression profiles
Bgee: expression breadth ubiquitous, 233 present calls, max score 97.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 190.4099 / max 809.1524, expressed in 1828 samples.
Highest expression (Bgee): ascending aorta, hindlimb stylopod muscle, thoracic aorta, popliteal artery, tibial artery.
Genetic regulation across tissues (GTEx eQTL / sQTL)
NUTF2 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 9 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
11 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Nerve Tibial | eqtl | 3.7e-03 | -0.27 | 16:67103074:TC:T |
| Esophagus Gastroesophageal Junction | eqtl | 1.0e-02 | +0.52 | 16:68374424:TGGAGCAGCA:T |
| Adipose Subcutaneous | eqtl | 1.4e-02 | +0.26 | 16:67072628:G:A |
| Cells EBV-transformed lymphocytes | eqtl | 1.8e-02 | -0.11 | 16:68201828:CATGCCTGTAGTCCCAGCTACTTGGGAGGCTGGCATAGGAGAA:C |
| Colon Transverse | eqtl | 2.0e-02 | -0.50 | 16:67408313:G:A |
| Whole Blood | eqtl | 2.1e-02 | -0.20 | 16:68828262:C:T |
| Brain Nucleus accumbens basal ganglia | eqtl | 2.7e-02 | -0.31 | 16:67937477:C:T |
| Esophagus Mucosa | sqtl | 2.8e-02 | -0.23 | 16:67657765:A:G |
| Nerve Tibial | sqtl | 3.2e-02 | -0.47 | 16:67530156:C:T |
| Muscle Skeletal | eqtl | 3.7e-02 | +0.17 | 16:67334057:G:A |
| Skin Sun Exposed Lower leg | eqtl | 4.1e-02 | -0.34 | 16:67279902:G:A |
FANTOM5 promoters
5 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154683 | 166.1076 | 1825 |
| 154684 | 12.8740 | 1780 |
| 154682 | 9.4450 | 1792 |
| 154685 | 1.4328 | 915 |
| 154681 | 0.5505 | 323 |
Top tissues by expression
showing 100 of 250 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ascending aorta | UBERON:0001496 | 97.25 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.25 | gold quality |
| thoracic aorta | UBERON:0001515 | 97.24 | gold quality |
| popliteal artery | UBERON:0002250 | 97.18 | gold quality |
| tibial artery | UBERON:0007610 | 97.18 | gold quality |
| aorta | UBERON:0000947 | 97.12 | gold quality |
| left coronary artery | UBERON:0001626 | 97.01 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 96.96 | gold quality |
| artery | UBERON:0001637 | 96.95 | gold quality |
| right coronary artery | UBERON:0001625 | 96.93 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 96.78 | gold quality |
| stromal cell of endometrium | CL:0002255 | 96.76 | gold quality |
| embryo | UBERON:0000922 | 96.70 | gold quality |
| ganglionic eminence | UBERON:0004023 | 96.70 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 96.57 | gold quality |
| lower esophagus | UBERON:0013473 | 96.56 | gold quality |
| hypothalamus | UBERON:0001898 | 96.49 | gold quality |
| amygdala | UBERON:0001876 | 96.48 | gold quality |
| coronary artery | UBERON:0001621 | 96.44 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 96.44 | gold quality |
| ventricular zone | UBERON:0003053 | 96.39 | gold quality |
| monocyte | CL:0000576 | 96.26 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 96.26 | gold quality |
| leukocyte | CL:0000738 | 96.21 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.21 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.20 | gold quality |
| skin of abdomen | UBERON:0001416 | 96.19 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.19 | gold quality |
| body of uterus | UBERON:0009853 | 96.19 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.18 | gold quality |
| left uterine tube | UBERON:0001303 | 96.13 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.09 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.06 | gold quality |
| right testis | UBERON:0004534 | 96.05 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.03 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.02 | gold quality |
| ectocervix | UBERON:0012249 | 95.97 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.94 | gold quality |
| endocervix | UBERON:0000458 | 95.89 | gold quality |
| muscle of leg | UBERON:0001383 | 95.89 | gold quality |
| spinal cord | UBERON:0002240 | 95.87 | gold quality |
| body of pancreas | UBERON:0001150 | 95.86 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.86 | gold quality |
| putamen | UBERON:0001874 | 95.81 | gold quality |
| apex of heart | UBERON:0002098 | 95.81 | gold quality |
| left testis | UBERON:0004533 | 95.78 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.74 | gold quality |
| skin of leg | UBERON:0001511 | 95.69 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 95.67 | gold quality |
| omental fat pad | UBERON:0010414 | 95.66 | gold quality |
| peritoneum | UBERON:0002358 | 95.63 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.63 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.60 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.58 | gold quality |
| cortical plate | UBERON:0005343 | 95.57 | gold quality |
| esophagus | UBERON:0001043 | 95.44 | gold quality |
| caudate nucleus | UBERON:0001873 | 95.42 | gold quality |
| right ovary | UBERON:0002118 | 95.41 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.36 | gold quality |
| vermiform appendix | UBERON:0001154 | 95.34 | gold quality |
| transverse colon | UBERON:0001157 | 95.32 | gold quality |
| tibial nerve | UBERON:0001323 | 95.19 | gold quality |
| body of stomach | UBERON:0001161 | 95.15 | gold quality |
| cardiac atrium | UBERON:0002081 | 95.14 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.09 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.03 | gold quality |
| right uterine tube | UBERON:0001302 | 95.00 | gold quality |
| left ovary | UBERON:0002119 | 94.97 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.96 | gold quality |
| rectum | UBERON:0001052 | 94.95 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.94 | gold quality |
| adrenal tissue | UBERON:0018303 | 94.93 | gold quality |
| minor salivary gland | UBERON:0001830 | 94.84 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.80 | gold quality |
| esophagus mucosa | UBERON:0002469 | 94.70 | gold quality |
| granulocyte | CL:0000094 | 94.69 | gold quality |
| right lung | UBERON:0002167 | 94.69 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.58 | gold quality |
| pancreas | UBERON:0001264 | 94.57 | gold quality |
| adrenal gland | UBERON:0002369 | 94.57 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.55 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 94.49 | gold quality |
| heart | UBERON:0000948 | 94.48 | gold quality |
| substantia nigra | UBERON:0002038 | 94.46 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 94.25 | gold quality |
| neocortex | UBERON:0001950 | 94.24 | gold quality |
| upper lobe of lung | UBERON:0008948 | 94.15 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 94.15 | gold quality |
| testis | UBERON:0000473 | 93.99 | gold quality |
| stomach | UBERON:0000945 | 93.96 | gold quality |
| lymph node | UBERON:0000029 | 93.85 | gold quality |
| frontal cortex | UBERON:0001870 | 93.85 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.84 | gold quality |
| muscle organ | UBERON:0001630 | 93.77 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 93.77 | gold quality |
| cortex of kidney | UBERON:0001225 | 93.68 | gold quality |
| thyroid gland | UBERON:0002046 | 93.63 | gold quality |
| pituitary gland | UBERON:0000007 | 93.62 | gold quality |
| midbrain | UBERON:0001891 | 93.62 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 826.32 |
| E-MTAB-8060 | no | 143.55 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Tongue | tissue | 161.0 | |
| Skeletal muscle | tissue | 142.5 | not detected |
| Locus coeruleus | tissue | 138.6 | |
| Heart muscle | tissue | 122.6 | not detected |
| Thymus | tissue | 114.0 | |
| Spinal cord | tissue | 109.3 | |
| Urinary bladder | tissue | 107.3 | medium |
| Placenta | tissue | 105.0 | low |
| Hippocampus | tissue | 102.5 | low |
| Smooth muscle | tissue | 99.6 | low |
| Nucleus accumbens | tissue | 96.0 | |
| Lymph node | tissue | 95.3 | low |
| Tonsil | tissue | 94.1 | medium |
| Postcentral gyrus | tissue | 90.0 | |
| Thalamus | tissue | 89.8 | |
| Ovary | tissue | 88.6 | medium |
| Pons | tissue | 87.9 | |
| Medulla oblongata | tissue | 87.8 | |
| Bone marrow | tissue | 87.0 | medium |
| Midbrain | tissue | 86.4 | |
| Colon | tissue | 85.6 | medium |
| Superior colliculi | tissue | 84.9 | |
| Parathyroid gland | tissue | 83.7 | medium |
| Putamen | tissue | 81.3 | |
| Fallopian tube | tissue | 79.1 | high |
| Substantia nigra | tissue | 78.0 | |
| Appendix | tissue | 77.5 | medium |
| Corpus callosum | tissue | 76.7 | |
| Choroid plexus | tissue | 76.5 | |
| Adipose tissue | tissue | 74.4 | not detected |
| Hippocampal formation | tissue | 73.9 | |
| Rectum | tissue | 73.3 | medium |
| Seminal vesicle | tissue | 72.8 | low |
| Cerebral cortex | tissue | 71.3 | low |
| Occipital cortex | tissue | 71.3 | |
| Esophagus | tissue | 71.1 | low |
| Pancreas | tissue | 70.3 | medium |
| Somatosensory cortex | tissue | 69.9 | |
| Epididymis | tissue | 69.3 | high |
| Cervix | tissue | 68.7 | medium |
| Breast | tissue | 68.2 | medium |
| Testis | tissue | 68.2 | high |
| Prefrontal cortex | tissue | 68.1 | |
| Motor cortex | tissue | 67.3 | |
| Hypothalamus | tissue | 65.9 | |
| Basal ganglia | tissue | 65.1 | not detected |
| Liver | tissue | 64.5 | low |
| Endometrium 1 | tissue | 63.9 | low |
| Ventral forebrain | tissue | 63.5 | |
| Adrenal gland | tissue | 61.7 | medium |
| Periaqueductal gray | tissue | 61.7 | |
| Septum | tissue | 61.5 | |
| Temporal cortex | tissue | 61.5 | |
| Entorhinal cortex | tissue | 60.4 | |
| Lung | tissue | 59.5 | high |
| Retrosplenial and cingulate cortex | tissue | 59.4 | |
| Spleen | tissue | 59.3 | not detected |
| Prostate | tissue | 59.1 | not detected |
| Salivary gland | tissue | 57.4 | low |
| Skin 1 | tissue | 57.2 | low |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Supraoptic nucleus (139.9), Lateral hypothalamic area (137.2), Lateral funiculus (white matter) (126.9), Anterior funiculus (white matter) (126.2), Median raphe nucleus (126.1).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MYC
miRNA regulators (miRDB)
Targeting NUTF2 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 56 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4648 | 99.91 | 67.00 | 710 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-4802-3P | 99.72 | 70.13 | 1273 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-1287-3P | 99.63 | 66.93 | 492 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-891B | 99.59 | 69.81 | 1083 |
| HSA-MIR-2113 | 99.58 | 71.22 | 1521 |
| HSA-MIR-18A-3P | 99.56 | 65.68 | 1092 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-548G-3P | 99.48 | 68.67 | 2159 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
Functional genomics
gnomAD constraint: pLI 0.99, LOEUF 0.403, missense Z 3.34 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000219169 — one region, missense o/e 0.27.
DepMap (CRISPR cell-line fitness): dependent in 99.3% of screened cell lines, common-essential.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): NCI-H226 (-2.866), LOU-NH91 (-2.676), Panc 03.27 (-2.507), NIH:OVCAR-3 (-2.354), DK-MG (-2.347), COLO-678 (-2.347), RERF-GC-1B (-2.336), OV-90 (-2.314), AsPC-1 (-2.27), NCI-H2052 (-2.162), MFE-280 (-2.134), NCI-H3122 (-2.134), RD-ES (-2.113), KP-4 (-2.087), SNU-626 (-2.069).
Literature-anchored findings (GeneRIF, showing 9)
- A nuclear pore binding site was studied on a mutated NTF2 protein. (PMID:15522285)
- Results report that NTF2 and Ran control nuclear import of the filamentous actin capping protein CapG. (PMID:18266911)
- NTF2 is a potential mediator of retinal vasculature integrity. (PMID:19404486)
- Data suggest actin accumulation in senescent cells is due to the failure of RanGTP restoration with ATP deficiency and NTF2 accumulation, resulting in decreased actin export via Exp6 inactivation. (PMID:21195711)
- Nucleocytoplasmic translocation of NTF2 is regulated in mammalian cells. (PMID:22880006)
- Binding of Ran to NTF2 is required for NTF2 to inhibit nuclear expansion and import of large cargo molecules. (PMID:26823604)
- These results showed that BLM enters the nucleus via the importin beta1, RanGDP and NTF2 dependent pathway, demonstrating for the first time the nuclear trafficking mechanism of a DNA helicase. (PMID:29017749)
- DNA-Origami NanoTrap for Studying the Selective Barriers Formed by Phenylalanine-Glycine-Rich Nucleoporins. (PMID:34324340)
- Nuclear Transport Factor 2 (NTF2) suppresses WM983B metastatic melanoma by modifying cell migration, metastasis, and gene expression. (PMID:34880267)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nutf2 | ENSDARG00000056531 |
| mus_musculus | Nutf2 | ENSMUSG00000008450 |
| mus_musculus | Nutf2-ps1 | ENSMUSG00000071497 |
| rattus_norvegicus | Nutf2 | ENSRNOG00000018945 |
| rattus_norvegicus | AABR07018058.1 | ENSRNOG00000057750 |
| drosophila_melanogaster | Ntf-2 | FBGN0031145 |
| drosophila_melanogaster | Ntf-2r | FBGN0032680 |
| caenorhabditis_elegans | ran-4 | WBGENE00004305 |
Paralogs (2): NXT2 (ENSG00000101888), NXT1 (ENSG00000132661)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1915301) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 4 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal lens morphology | 1 |
| cataract | 1 |
| decreased heart rate | 1 |
| preweaning lethality, complete penetrance | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q32KP9 | 100.0% | Diamond |
| Pongo abelii | Q5R8G4 | 100.0% | Diamond |
| Nakaseomyces glabratus CBS 138 | Q6FRC6 | 93.6% | Diamond |
| Eremothecium gossypii ATCC 10895 | Q75AA5 | 93.6% | Diamond |
| Saccharomyces cerevisiae S288C | P33331 | 92.8% | Diamond |
| Kluyveromyces lactis NRRL Y-1140 | Q6CQX4 | 91.2% | Diamond |
| Debaryomyces hansenii CBS767 | Q6BWC0 | 88.7% | Diamond |
| Candida albicans | Q9P926 | 88.7% | Diamond |
| Xenopus laevis | O42242 | 86.6% | Diamond |
| Arabidopsis thaliana | Q9C7F5 | 84.6% | Diamond |
| Schizosaccharomyces pombe 972h- | Q10100 | 71.7% | Diamond |
| Oryza sativa Japonica Group | Q9XJ54 | 70.2% | Diamond |
| Yarrowia lipolytica CLIB122 | Q6CC82 | 68.3% | Diamond |
| Cladosporium herbarum | Q8NJ52 | 65.6% | Diamond |
| Aspergillus nidulans FGSC A4 | Q96VN3 | 65.6% | Diamond |
| Neurospora crassa OR74A | P87102 | 57.5% | Diamond |
| Dictyostelium discoideum | Q86HW7 | 44.3% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CTRL | protein-coding | 1506 |
| EDC4 | protein-coding | 23644 |
| PSKH1 | protein-coding | 5681 |
| PSMB10 | protein-coding | 5699 |
| CENPT | protein-coding | 80152 |
| C16orf86 | protein-coding | 388284 |
| TSNAXIP1 | protein-coding | 55815 |
| THAP11 | protein-coding | 57215 |
| RANBP10 | protein-coding | 57610 |
| GFOD2 | protein-coding | 81577 |
| NRN1L | protein-coding | 123904 |
Protein
Protein identifiers
Nuclear transport factor 2 — P61970 (reviewed: P61970)
Alternative names: Placental protein 15
All UniProt accessions (7): A0A8V8TPY3, A0A8V8TR25, A0A8V8TR28, A0A8V8TRD3, B4DEQ2, P61970, H3BRV9
UniProt curated annotations — full annotation on UniProt →
Function. Mediates the import of GDP-bound RAN from the cytoplasm into the nucleus which is essential for the function of RAN in cargo receptor-mediated nucleocytoplasmic transport. Thereby, plays indirectly a more general role in cargo receptor-mediated nucleocytoplasmic transport. Interacts with GDP-bound RAN in the cytosol, recruits it to the nuclear pore complex via its interaction with nucleoporins and promotes its nuclear import.
Subunit / interactions. Homodimer. Interacts with RAN (GDP-bound form); the interaction is direct and regulates RAN nuclear import. Interacts with the nucleoporins NUP54, NUP58 and NUP62 (via FG repeats); recruits NUTF2 to the nuclear pore complex a step required for NUTF2-mediated GDP-bound RAN nuclear import. Interacts with CAPG; mediates its nuclear import.
Subcellular location. Cytoplasm. Cytosol. Nucleus outer membrane. Nucleus. Nuclear pore complex. Nucleus inner membrane. Nucleoplasm.
RefSeq proteins (5): NP_001308967, NP_001308968, NP_001308969, NP_001308970, NP_005787* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002075 | NTF2_dom | Domain |
| IPR018222 | Nuclear_transport_factor_2_euk | Domain |
| IPR032710 | NTF2-like_dom_sf | Homologous_superfamily |
| IPR045875 | NTF2 | Family |
Pfam: PF02136
UniProt features (14 total): strand 6, helix 3, mutagenesis site 2, chain 1, domain 1, modified residue 1
Structure
Experimental structures (PDB)
1 structure by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 1GY5 | D92N,D94N double point mutant of human Nuclear Transport Factor 2 (NTF2) | X-RAY DIFFRACTION | 2.3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P61970-F1 | 95.29 | 0.93 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Plasma proteins, Essential proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH supported
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1)
| Type | Positions |
|---|---|
| N6-acetyllysine | 4 |
Mutagenesis-validated functional residues (2)
| Position | Phenotype |
|---|---|
| 42 | no effect on localization to the nucleoplasm. |
| 124 | no effect on localization to the nucleoplasm. |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 209 (showing top):
MYAATNNNNNNNGGC_UNKNOWN, E2F_Q4_01, chr16q22, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, KAAB_FAILED_HEART_ATRIUM_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, RACCACAR_AML_Q6, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOMF_GTPASE_BINDING, GGAMTNNNNNTCCY_UNKNOWN, CAGCTG_AP4_Q5, PUJANA_CHEK2_PCC_NETWORK, GOBP_NUCLEAR_TRANSPORT, AAACCAC_MIR140
GO Biological Process (6): protein import into nucleus (GO:0006606), protein export from nucleus (GO:0006611), mRNA transport (GO:0051028), protein localization to nuclear pore (GO:0090204), nucleocytoplasmic transport (GO:0006913), protein transport (GO:0015031)
GO Molecular Function (5): structural constituent of nuclear pore (GO:0017056), small GTPase binding (GO:0031267), identical protein binding (GO:0042802), nuclear import signal receptor activity (GO:0061608), protein binding (GO:0005515)
GO Cellular Component (10): nuclear inner membrane (GO:0005637), nuclear outer membrane (GO:0005640), nucleoplasm (GO:0005654), cytosol (GO:0005829), nuclear membrane (GO:0031965), nuclear pore central transport channel (GO:0044613), extracellular exosome (GO:0070062), nucleus (GO:0005634), nuclear pore (GO:0005643), cytoplasm (GO:0005737)
GO top-level categories
32 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| intracellular protein transport | 2 |
| import into nucleus | 2 |
| nuclear pore | 2 |
| nuclear membrane | 2 |
| nuclear envelope | 2 |
| nuclear protein-containing complex | 2 |
| protein localization to nucleus | 1 |
| establishment of protein localization to organelle | 1 |
| nuclear export | 1 |
| RNA transport | 1 |
| protein localization to nuclear envelope | 1 |
| nuclear transport | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| structural molecule activity | 1 |
| nucleocytoplasmic transport | 1 |
| GTPase binding | 1 |
| protein binding | 1 |
| nucleocytoplasmic carrier activity | 1 |
| binding | 1 |
| organelle inner membrane | 1 |
| organelle outer membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| nucleus | 1 |
| organelle membrane | 1 |
| extracellular vesicle | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 8 of 21 annotations. The rest are phylogenetic / computational / electronic (IEA).
8 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| protein export from nucleus | BP | direct assay |
| protein import into nucleus | BP | direct assay |
| cytosol | CC | direct assay |
| extracellular exosome | CC | high-throughput assay |
| nucleoplasm | CC | direct assay |
| identical protein binding | MF | physical interaction |
| small GTPase binding | MF | direct assay |
| structural constituent of nuclear pore | MF | direct assay |
Protein interactions and networks
IntAct
Human interaction partners of NUTF2 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
showing 30 of 46 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| RAN | physical association | 0.890 | 4 |
| NUP62 | physical association | 0.780 | 7 |
| BEND7 | physical association | 0.560 | 3 |
| BRWD1 | physical association | 0.560 | 3 |
| CAMK2G | physical association | 0.560 | 3 |
| CCDC106 | physical association | 0.560 | 3 |
| CCDC150 | physical association | 0.560 | 3 |
| CHCHD3 | physical association | 0.560 | 3 |
| CHMP4A | physical association | 0.560 | 3 |
| CKMT1A | physical association | 0.560 | 3 |
| CLPP | physical association | 0.560 | 3 |
| FAM50B | physical association | 0.560 | 3 |
| HMG20A | physical association | 0.560 | 3 |
| HMG20B | physical association | 0.560 | 3 |
| KHDC4 | physical association | 0.560 | 3 |
| KRT86 | physical association | 0.560 | 3 |
| KRTAP9-8 | physical association | 0.560 | 3 |
| LASP1 | physical association | 0.560 | 3 |
| LCE1C | physical association | 0.560 | 3 |
| LCE5A | physical association | 0.560 | 3 |
| LENG1 | physical association | 0.560 | 3 |
| MRNIP | physical association | 0.560 | 3 |
| MYOZ3 | physical association | 0.560 | 3 |
| NME1 | physical association | 0.560 | 3 |
| NME4 | physical association | 0.560 | 3 |
| NRIP3 | physical association | 0.560 | 3 |
| NUP54 | physical association | 0.560 | 3 |
| PAX4 | physical association | 0.560 | 3 |
| PBX4 | physical association | 0.560 | 3 |
| PCNA | physical association | 0.560 | 3 |
BioGRID (154 interactions; top human partners by supporting records): RAN (Two-hybrid; 11 records), NUP62 (Two-hybrid; 5 records), NUP153 (Reconstituted Complex; 3 records), KPNB1 (Reconstituted Complex; 2 records), NUP54 (Two-hybrid; 2 records), NUP93 (Affinity Capture-MS; 2 records), NXF1 (Affinity Capture-RNA; 2 records), AES (Two-hybrid), AGR2 (Proximity Label-MS), AP2A1 (Co-fractionation), AP2A2 (Co-fractionation), APOA1BP (Co-fractionation), BAG1 (Affinity Capture-MS), BAP1 (Affinity Capture-MS), BEND7 (Two-hybrid)
SIGNOR signaling
1 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| NUTF2 | “up-regulates activity” | NUP62 | binding |
Disease & clinical
Genetic variants
Variant evidence for NUTF2: 11 ClinVar records (0 pathogenic / likely pathogenic); 3 GWAS associations.
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 37 predictions of 325):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 16:67868338–67868339 | acceptor_loss | 1.0000 | 5 |
| 16:67868600–67868601 | donor_loss | 1.0000 | 5 |
| 16:67870798–67870799 | acceptor_loss | 1.0000 | 6 |
| 16:67846986–67846987 | donor_loss | 0.9900 | 5 |
| 16:67865191 | donor_gain | 0.9900 | |
| 16:67868339 | acceptor_loss | 0.9900 | |
| 16:67868412–67868413 | donor_loss | 0.9900 | 6 |
| 16:67868421 | donor_gain | 0.9900 | |
| 16:67868499–67868500 | acceptor_loss | 0.9900 | 6 |
| 16:67870797 | acceptor_gain | 0.9900 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
5 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | unfavorable | 1.4e-06 |
| Head and Neck Squamous Cell Carcinoma (TCGA) | unfavorable | 8.54e-05 |
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 0.000121 |
| Kidney Renal Clear Cell Carcinoma (validation) | unfavorable | 0.00034 |
| Liver Hepatocellular Carcinoma (validation) | unfavorable | 0.000497 |
Disease associations
OMIM: gene MIM:605813 | disease phenotypes:
GWAS associations
3 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST010002_165 | Refractive error | 2e-14 |
| GCST002539_44 | Schizophrenia | 2e-8 |
| GCST006803_78 | Schizophrenia | 4e-8 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067085 (SINGLE PROTEIN)
PharmGKB: 1 entry (CPIC guideline: no)
Binding affinities (BindingDB)
1 measured of 1 human assays (2 total across all organisms); most potent 1 below. Values come from heterogeneous assays and are not directly comparable.
| Ligand | Measure | Value |
|---|---|---|
| CHEMBL5653589 | KD | 1440 nM |
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.66 | Kd | 2.171 | nM | CHEMBL3752910 |
| 8.66 | ED50 | 2.171 | nM | CHEMBL3752910 |
| 6.38 | Kd | 419.2 | nM | CHEMBL5653589 |
| 6.38 | ED50 | 419.2 | nM | CHEMBL5653589 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148908: Binding affinity to human NUTF2 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0022 | uM |
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148908: Binding affinity to human NUTF2 incubated for 45 mins by Kinobead based pull down assay | kd | 0.4192 | uM |
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, increases expression | 3 |
| Valproic Acid | decreases expression, increases expression, affects cotreatment | 3 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression, decreases expression | 2 |
| Tretinoin | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | increases expression | 1 |
| nobiletin | decreases expression, decreases reaction | 1 |
| sodium arsenate | decreases expression, decreases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| ochratoxin A | increases expression | 1 |
| tamibarotene | affects expression | 1 |
| microcystin RR | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| K 7174 | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| LDN 193189 | affects cotreatment, increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Ivermectin | decreases expression | 1 |
| Selenium | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Theophylline | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Vitamin E | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651950 | Binding | Binding affinity to human NUTF2 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — *ChemMedChem* |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Predicted chemistry — Sugi Predict
The predicted patent-compound landscape for NUTF2 across ~30M SureChEMBL compounds — explore on Sugi Predict.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.